# Gut-derived biofilm-forming bacteria as a source of catheter-associated infections: inhibitory effects of O-alkyl naringenin derivatives

**Authors:** Anna Duda-Madej, Wojciech Tabor, Szymon Viscardi, Monika Oleksy-Wawrzyniak, Joanna Kozłowska, Przemysław Gagat, Agnieszka Grabowiecka

PMC · DOI: 10.3389/fcimb.2026.1768480 · Frontiers in Cellular and Infection Microbiology · 2026-03-13

## TL;DR

This study explores new O-alkyl naringenin derivatives that can inhibit biofilm formation by bacteria causing catheter-associated infections.

## Contribution

The paper introduces novel O-alkyl naringenin derivatives with antimicrobial and anti-biofilm activity against clinical strains of E. coli and S. aureus.

## Key findings

- 7-O-methylnaringenin oxime significantly reduced planktonic growth of E. coli and S. aureus by 43.2% and 74.6%, respectively.
- Oximes of 7-O-methylnaringenin and 7-O-isopropylnaringenin impaired biofilm growth under static and simulated flow conditions.
- The derivatives showed biofilm-specific mechanisms beyond antimicrobial activity in catheter-like flow conditions.

## Abstract

The capacity for biofilm formation is a fundamental defense mechanism among antimicrobial-resistant pathogenic strains. In addition, its persistence may result in chronic colonization of host systems, and uncontrolled growth may lead to dangerous flow blockages, particularly in catheter-associated urinary tract infections. This warrants the search for novel anti-biofilm compounds to combat these pathogens. Naringenin is an example of such a structure, widely known for its multifunctional activity, targeting the synthesis of exopolysaccharide, the expression of biofilm-relevant genes, or efflux pump activity. In this study, we present a series of O-alkyl derivatives of naringenin and its oximes, that exhibited antimicrobial and biofilm-reducing activity against clinical strains of Escherichia coli and Staphylococcus aureus, which are often the cause of urinary tract infections. Most of the derivatives were highly active against the planktonic form of bacteria, the most potent of them being 7-O-methylnaringenin oxime, diminishing the growth of E. coli and S. aureus by 43.2% and 74.6%, respectively. The initial screening of the antibiofilm capabilities of the derivatives was performed in static conditions in a gravimetric method utilizing quartz tuning forks. While most of them were significantly less active than against the planktonic form, the oximes of 7-O-methylnaringenin and 7-O-isopropylnaringenin were found to impair the growth of biofilm in case of both strains. Therefore, the observed reduction in biofilm mass under static conditions may reflect not only antimicrobial activity but also biofilm-specific mechanisms, as indicated by the use of flow conditions with catheters simulating urine flux. These studies confirmed the activity of 7-O-methylnaringenin oxime, which reduced E. coli CCM 5712 population.

## Linked entities

- **Chemicals:** naringenin (PubChem CID 932), 7-O-methylnaringenin (PubChem CID 73571)
- **Species:** Escherichia coli (taxon 562), Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** infections (MESH:D007239), urinary tract infections (MESH:D014552)
- **Chemicals:** 7-O-isopropylnaringenin (-), Naringenin (MESH:C005273), oximes (MESH:D010091)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13021772/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13021772/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC13021772/full.md

---
Source: https://tomesphere.com/paper/PMC13021772